Suppr超能文献

心脏磁共振成像联合同步性和瘢痕显像预测心脏再同步治疗后的临床反应和长期预后。

Combined dyssynchrony and scar imaging with cardiac magnetic resonance imaging predicts clinical response and long-term prognosis following cardiac resynchronization therapy.

机构信息

Alfred Hospital Heart Centre, Baker IDI Heart and Diabetes Research Institute, Commercial Road, Melbourne, VIC 3004, Australia.

出版信息

Europace. 2010 May;12(5):708-13. doi: 10.1093/europace/euq047. Epub 2010 Feb 27.

Abstract

AIMS

Cardiac resynchronization therapy (CRT) is advocated in advanced heart failure; however, patient selection remains challenging. We examined the utility of multi-sequential cardiac magnetic resonance imaging (CMR) in predicting outcome after CRT.

METHODS AND RESULTS

We performed multi-sequential CMR on 40 subjects with cardiomyopathy and advanced heart failure, despite optimized medical therapy. All patients had been recommended for CRT according to accepted clinical guidelines. Patients were defined by CMR as likely responders if they had significant mechanical dyssynchrony (> or =65 ms delay between septal and posterolateral wall contraction on cine imaging), and no transmural scarring of the anteroseptal or posterolateral wall on delayed contrast-enhanced imaging. Clinical composite score was recorded at baseline and 6 months post-CRT. Long-term follow-up (transplant-free survival) was 497 +/- 55 days post-CRT. A clinical response was achieved in 19/26 (73%) of the CMR-predicted responders and 2/12 (17%) of the CMR-predicted non-responders (P < 0.01, chi(2)). The sensitivity of CMR for prediction of clinical response to CRT was 90%, with a specificity of 59%. Transplant-free survival post-CRT was achieved in 88% of the CMR-predicted responders and 58% of the CMR-predicted non-responders (P < 0.05, Kaplan-Meier survival analysis).

CONCLUSION

Multi-sequential CMR identifies patients with severe cardiomyopathy who will respond to CRT with a favourable long-term prognosis.

摘要

目的

心脏再同步治疗(CRT)被提倡用于晚期心力衰竭;然而,患者选择仍然具有挑战性。我们研究了多序列心脏磁共振成像(CMR)在预测 CRT 后结局中的作用。

方法和结果

我们对 40 名患有心肌病和晚期心力衰竭的患者进行了多序列 CMR 检查,尽管已经进行了优化的药物治疗。所有患者均根据公认的临床指南被推荐接受 CRT。如果患者在电影成像上存在明显的机械不同步(间隔和后外侧壁收缩之间存在 > 或 =65ms 的延迟),并且在延迟对比增强成像上不存在前间隔和后外侧壁的透壁瘢痕,则 CMR 将其定义为可能的反应者。在 CRT 后 6 个月记录临床综合评分。长期随访(移植无存活)为 CRT 后 497 +/- 55 天。在 CMR 预测的反应者中,19/26(73%)例患者获得临床反应,而在 CMR 预测的非反应者中,2/12(17%)例患者获得临床反应(P < 0.01,卡方检验)。CMR 预测 CRT 临床反应的敏感性为 90%,特异性为 59%。在 CMR 预测的反应者中,88%的患者在 CRT 后获得移植无存活,而在 CMR 预测的非反应者中,58%的患者获得移植无存活(P < 0.05,Kaplan-Meier 生存分析)。

结论

多序列 CMR 可识别出患有严重心肌病的患者,这些患者对 CRT 有良好的长期预后反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验